Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Acorda Therapeutics

NASDAQ ACOR
$0.0000 -0.66 -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

-
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
157.37M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.58
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
964.38K
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-100.00 %

Upcoming events Acorda Therapeutics

All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Acorda Therapeutics

Stock analysis Acorda Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
- 25.03
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 3.57
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
5.52 9.56
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
5.52 -0.17
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
287.29 7.67

Price change Acorda Therapeutics per year

3.27$ 8.66$
Min Max

Summary analysis Acorda Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Acorda Therapeutics

Revenue and net income Acorda Therapeutics

All parameters

Stock news Acorda Therapeutics

All news
11 January в 16:30

Acorda Therapeutics: Biogen Ending Fampyra Collaboration

11 January в 16:30

Acorda Therapeutics: Biogen Ending Fampyra Collaboration

8 May 2023 в 20:10

Acorda Therapeutics Shares Soar 75% After Signing China Distribution Deal for Inbrija

8 May 2023 в 20:10

Acorda Therapeutics Shares Soar 75% After Signing China Distribution Deal for Inbrija

8 May 2023 в 14:36

Acorda Therapeutics in China Distribution Pact for Inbrija

8 May 2023 в 14:36

Acorda Therapeutics in China Distribution Pact for Inbrija

15 June 2022 в 01:40

Acorda Therapeutics Says Unknown Actor Accessed Emails in December

15 June 2022 в 01:40

Acorda Therapeutics Says Unknown Actor Accessed Emails in December

23 July 2021 в 14:29

Acorda Therapeutics Shares up After Deal to Commercialize Inbrija in Spain

23 July 2021 в 14:29

Acorda Therapeutics Shares up After Deal to Commercialize Inbrija in Spain

4 September 2020 в 18:27

Лидеры и аутсайдеры Уолл-cтрит: Kensington Capital Acquisition, Tortoise Acquisition, Acorda Therapeutics

About company Acorda Therapeutics

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol dependence; and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
Address:
420 Saw Mill River Road, Ardsley, NY, United States, 10502
Company name: Acorda Therapeutics
Issuer ticker: ACOR
ISIN: US00484M6012
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2006-02-10
Sector: Healthcare
Industry: Biotechnology
Site: https://www.acorda.com

On which stock exchange are Acorda Therapeutics (ACOR) stocks traded?

Acorda Therapeutics (ACOR) stocks are traded on NASDAQ.

What is the ticker of Acorda Therapeutics stocks (ACOR)?

The stock ticker of Acorda Therapeutics’s stocks or in other words, the code is ACOR. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Acorda Therapeutics (ACOR) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Acorda Therapeutics (ACOR) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Acorda Therapeutics (ACOR) stocks traded?

Acorda Therapeutics (ACOR) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Acorda Therapeutics (ACOR) stocks today?

The current price of Acorda Therapeutics stocks on 05.05.2024 is 0 dollars. per share.

What is the dynamics of Acorda Therapeutics (ACOR) stocks from the beginning of the year?

Acorda Therapeutics (ACOR) quotes have increased by -100% from the beginning of the year up to 0 dollars. per 1 stocks.

How much did Acorda Therapeutics (ACOR) stocks increase in мае 2024?

This month Acorda Therapeutics (ACOR) quotes have increased by 0% to 0 dollars. per share.

How much are Acorda Therapeutics (ACOR) stocks worth?

Today, on October, 05.05.2024 Acorda Therapeutics’s (ACOR) stocks cost 0 dollars..

What is the market capitalization of Acorda Therapeutics (ACOR)?

Capitalization is the market value of Acorda Therapeutics (ACOR) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 05.05.2024, the market capitalization of Acorda Therapeutics (ACOR) is estimated at about 0 dollars.